Adimmune Corporation (TPE: 4142)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.00
-0.10 (-0.45%)
Jan 20, 2025, 1:30 PM CST
-29.15%
Market Cap 9.32B
Revenue (ttm) 1.57B
Net Income (ttm) -608.33M
Shares Out 421.51M
EPS (ttm) -1.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,162,420
Average Volume 9,305,939
Open 22.00
Previous Close 22.10
Day's Range 21.70 - 22.35
52-Week Range 19.15 - 31.40
Beta 0.52
RSI 50.07
Earnings Date Mar 28, 2025

About Adimmune

Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; and purified Tuberculin, as well as contract manufacturing services. The compan... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1965
Employees 564
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4142
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.